Meta-analysis of hematologic toxicities in patients with cancer treated with sunitinib

被引：0
|
作者：
Funakoshi, Tomohiro
Latif, Asma
Arasteh, Kamyar
Galsky, Matt D.
机构：
[1] Beth Israel Deaconess Med Ctr, New York, NY 10003 USA
[2] Mt Sinai Sch Med, Div Hematol & Med Oncol, Tisch Canc Inst, New York, NY USA
[3] Beth Israel Deaconess Med Ctr, Baron Edmond de Rothschild Chem Dependency Inst, New York, NY 10003 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 06期
关键词：
D O I：
10.1200/jco.2013.31.6_suppl.373
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
373
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Risk of hematologic toxicities in cancer patients treated with sunitinib: A systematic review and meta-analysis
    Funakoshi, Tomohiro
    Latif, Asma
    Galsky, Matthew D.
    CANCER TREATMENT REVIEWS, 2013, 39 (07) : 818 - 830
  • [2] Cardiovascular Toxicities Risk with Sunitinib in Cancer Patients: a Meta-analysis
    Wang, Wanting
    Feng, Zhaoqiang
    Bai, Jinghui
    LATIN AMERICAN JOURNAL OF PHARMACY, 2023, 42 (03): : 627 - 635
  • [3] Hematologic toxicities of sunitinib in patients with gastrointestinal stromal tumors: a systematic review and meta-analysis
    Jiang, Xuehui
    Xiong, Fangfang
    Fu, Qun
    Peng, Hongwei
    Jing, Yan
    Rexiti, Kaisaner
    Wei, Xiaohua
    Tao, Song
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2022, 37 (07) : 1525 - 1534
  • [4] Hematologic toxicities of sunitinib in patients with gastrointestinal stromal tumors: a systematic review and meta-analysis
    Xuehui Jiang
    Fangfang Xiong
    Qun Fu
    Hongwei Peng
    Yan Jing
    Kaisaner Rexiti
    Xiaohua Wei
    Song Tao
    International Journal of Colorectal Disease, 2022, 37 : 1525 - 1534
  • [5] Meta-analysis of hematologic toxicities in patients with solid tumors treated with everolimus
    Funakoshi, Tomohiro
    Latif, Asma
    Galsky, Matt D.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [6] Hematologic toxicities in cancer patients treated with the multityrosine Kinase sorafenib: A meta-analysis of clinical trials
    Schutz, F. A.
    Je, Y.
    Choueiri, T. K.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (07)
  • [7] Risk of severe hematologic toxicities in cancer patients treated with PARP inhibitors: a meta-analysis of randomized controlled trials
    Zhou, Jian xin
    Feng, Li jin
    Zhang, Xi
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2017, 11 : 3009 - 3017
  • [8] Hematologic toxicities in cancer patients treated with the multi-tyrosine kinase sorafenib: A meta-analysis of clinical trials
    Schutz, Fabio A. B.
    Je, Youjin
    Choueiri, Toni K.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2011, 80 (02) : 291 - 300
  • [9] Risk of hematologic toxicities in patients with solid tumors treated with everolimus: A systematic review and meta-analysis
    Funakoshi, Tomohiro
    Latif, Asma
    Galsky, Matthew D.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2013, 88 (01) : 30 - 41
  • [10] Risk of hypothyroidism in patients with cancer treated with sunitinib: A systematic review and meta-analysis
    Funakoshi, Tomohiro
    Shimada, Yuichi J.
    ACTA ONCOLOGICA, 2013, 52 (04) : 691 - 702
12345